Nourish is a telehealth platform that enhances health by facilitating access to clinical-grade nutrition care through a network of registered dietitians. The company specializes in evidence-based nutritional counseling, offering personalized telenutrition therapy that is covered by health insurance. This approach empowers individuals to improve their health and wellness by making it easier to eat well and achieve their nutrition goals.
Chapter is a company that specializes in Medicare advisory services aimed at helping seniors navigate their health coverage options. By offering a comprehensive Medicare navigation platform, Chapter assists retirees in making informed decisions regarding their health insurance, ensuring they select coverage that best suits their individual needs while minimizing costs. The platform fosters transparency by aligning the interests of Medicare advisors and consumers, enabling independent recommendations that consider a wide range of options. In addition to health coverage support, Chapter provides retirees with tailored resources such as coupons, tax advice, and technology tips, all designed to enhance their quality of life and security as they age.
Daymark Health
Seed Round in 2025
Daymark Health is a healthcare company specializing in supportive care services for cancer patients. It connects primary care physicians, oncologists, and care teams to provide virtual and home-based care, symptom management, care navigation, social support, and mental health services. These services are delivered by nurse practitioners, social workers, and health partners, ensuring comprehensive, personalized care that addresses both medical and non-medical needs throughout the patient's treatment journey.
AheadComputing
Seed Round in 2025
AheadComputing is a technology company that designs and licenses high-performance microprocessor cores, along with related support services. Their focus is on RISC-V core intellectual property, offering scalable solutions for next-generation embedded systems. By providing efficient and scalable embedded systems, AheadComputing helps clients enhance performance, reduce power consumption, and accelerate time-to-market for their devices across diverse applications.
Aligned Marketplace
Seed Round in 2025
Aligned Marketplace is a national healthcare provider that offers personalized, advanced primary care services to employees of self-insured companies. It operates a network of local offices and virtual care options, delivering proactive, coordinated care through a value-based model. This includes same-day/next-day appointments and complete access to primary care services, all administered through a single, shared savings arrangement with employers.
Esperto Medical
Series A in 2024
Esperto Medical is a medical device company based in Irvine, California, focused on developing advanced wearable diagnostics for both hospital and remote patient monitoring. The company utilizes innovative resonance sonomanometry technology, which employs acoustic stimulation to provide continuous and noninvasive blood pressure measurements without the need for calibration. By enabling round-the-clock monitoring of vital signs, Esperto Medical’s devices aim to enhance accessibility to medical care through automation, allowing patients to effectively manage their health from home or within clinical settings.
Terray Therapeutics
Series B in 2024
Terray Therapeutics, founded in 2018 and based in Pasadena, California, is a biotechnology company dedicated to advancing drug discovery for intractable diseases. It operates a unique platform that combines experimentation and computation to efficiently explore chemical space, generating precise data through rapid design-make-test-analyze cycles. The company employs artificial intelligence, synthetic chemistry, automation, and nanotechnology to create comprehensive datasets using ultra-dense microarray technology. These datasets systematically map biochemical interactions between small molecules and disease targets, enabling iterative cycles of virtual molecular design and experimentation that guide AI and machine learning models for predictive insights in drug discovery.
TensorWave
Venture Round in 2024
TensorWave specializes in providing advanced AI and high-performance computing (HPC) cloud infrastructure. It offers scalable, memory-optimized technology powered by AMD Instinct GPUs, ensuring high performance and energy efficiency for demanding AI and machine learning workloads. The company's services include direct liquid cooling, high-speed network storage, and seamless integration capabilities, enabling enterprises to effectively harness the power of artificial intelligence.
Orasis Pharmaceuticals
Series D in 2024
Orasis Pharmaceuticals Ltd is a pharmaceutical company based in Herzliya, Israel, founded in 2015. The company specializes in the development of corrective eye drops aimed at treating presbyopia, a common age-related vision condition. Its primary product, CSF-1, is designed to improve near visual acuity through pupil modulation, thereby alleviating the need for reading glasses. By repurposing existing, well-studied molecules, CSF-1 aims to provide an effective, safe, and easy-to-use solution that enhances the quality of life for individuals affected by presbyopia. This noninvasive treatment option offers patients a practical alternative for managing their near vision difficulties.
Spear Bio
Series A in 2024
Spear Bio is a biotechnology company based in Weston, Massachusetts, founded in 2021. The company specializes in ultrasensitive protein detection technology, which significantly enhances healthcare diagnostics. Its innovative approach enables the quantification of minute protein biomarkers from samples collected at home, facilitating self-testing and telemedicine applications. By allowing clinicians to detect these biomarkers from small sample volumes, Spear Bio's technology integrates seamlessly into existing workflows for sample collection, processing, and detection, thereby improving the overall efficiency of healthcare delivery.
Daffodil Health
Seed Round in 2024
Daffodil Health is a pediatric behavioral health platform focused on providing support for special needs children and their families. The company offers a comprehensive platform that guides parents navigating the complexities of their neurodiverse child's development. Through an initial questionnaire designed for parents who observe developmental challenges in their children, Daffodil Health facilitates a free online consultation to discuss the responses and identify suitable therapeutic programs. This approach empowers parents to take an active role in managing their child's behavioral health journey, utilizing multi-modal therapies and real-time support tailored to their specific needs.
Chapter is a company that specializes in Medicare advisory services aimed at helping seniors navigate their health coverage options. By offering a comprehensive Medicare navigation platform, Chapter assists retirees in making informed decisions regarding their health insurance, ensuring they select coverage that best suits their individual needs while minimizing costs. The platform fosters transparency by aligning the interests of Medicare advisors and consumers, enabling independent recommendations that consider a wide range of options. In addition to health coverage support, Chapter provides retirees with tailored resources such as coupons, tax advice, and technology tips, all designed to enhance their quality of life and security as they age.
Thintronics
Series A in 2024
Thintronics is a consumer electronics company specializing in materials science. It develops a platform that enhances data transfer speeds and reduces energy consumption in electronic devices. This is achieved through innovative thin-film materials, benefiting industries like artificial intelligence, data centers, and radio frequency systems.
Clarity Pediatrics
Seed Round in 2024
Clarity Pediatrics is a healthcare company focused on transforming pediatric chronic care, specifically for children diagnosed with ADHD. With nearly 10% of American children affected by this condition, the company aims to alleviate the challenges parents face in accessing appropriate care. Clarity Pediatrics has developed a virtual pediatric ADHD clinic that leverages a tech-enabled clinical model, offering features such as video conferencing, secure messaging, and electronic health records. This innovative approach is designed to deliver high-quality, evidence-based care to families, regardless of their location or insurance status. Through its platform, Clarity Pediatrics strives to achieve exceptional health outcomes that can significantly improve the developmental trajectory of affected children.
Auradine is a provider of web infrastructure solutions focused on blockchain, security, and privacy. The company develops a comprehensive platform that encompasses hardware, software, and cloud services, aimed at creating scalable, sustainable, and secure infrastructure. With a proven track record in security, software-as-a-service, semiconductors, and systems, Auradine leverages cutting-edge technologies to deliver innovative infrastructure solutions tailored to meet the needs of its clients.
SiMa Technologies, Inc. specializes in developing machine learning technology for embedded systems, offering a comprehensive machine learning system-on-chip (MLSoC) platform. Founded in 2018 and headquartered in San Jose, California, the company focuses on delivering high-performance machine learning capabilities with low power consumption. Its MLSoC enables seamless deployment and scaling of machine learning applications at the edge, enhancing performance and energy efficiency for various use cases, including computer vision and generative AI. The platform supports diverse frameworks, models, and sensors, ensuring flexibility and adaptability for customers. Additionally, SiMa's solutions incorporate security features, such as threat detection, to safeguard against potential cyber risks, thereby providing a robust environment for embedded edge applications.
Aligned Marketplace
Seed Round in 2024
Aligned Marketplace is a national healthcare provider that offers personalized, advanced primary care services to employees of self-insured companies. It operates a network of local offices and virtual care options, delivering proactive, coordinated care through a value-based model. This includes same-day/next-day appointments and complete access to primary care services, all administered through a single, shared savings arrangement with employers.
Nourish is a telehealth platform that enhances health by facilitating access to clinical-grade nutrition care through a network of registered dietitians. The company specializes in evidence-based nutritional counseling, offering personalized telenutrition therapy that is covered by health insurance. This approach empowers individuals to improve their health and wellness by making it easier to eat well and achieve their nutrition goals.
BlueFlag Security
Seed Round in 2024
BlueFlag Security is a comprehensive security services provider, safeguarding businesses and individuals through a multi-layered defense platform. This platform integrates identity security, open-source software risk management, and developer tool posture management, offering robust protection against evolving cyber threats.
Oula Health
Series B in 2024
Oula Health, Inc. is a maternity care provider based in Brooklyn, New York, established in 2019. The company focuses on redesigning maternity care by integrating obstetrics and midwifery to create a personalized and evidence-based experience for expecting families. Oula operates clinics and offers home-based prenatal care services, aiming to set a new standard for pregnancy care that harmonizes modern medical practices with a compassionate approach. Through its innovative model, Oula Health seeks to enhance the overall maternity care experience for its clients.
Areteia Therapeutics
Series A in 2024
Areteia Therapeutics is a biotechnology company focused on developing innovative treatments for asthma, particularly eosinophilic asthma. Spun out from Knopp in Pennsylvania, the company aims to empower asthma patients by providing them with better control over their condition. Areteia is advancing an oral drug candidate that works by inhibiting the maturation of eosinophils, which are immune cells that can damage the airways and exacerbate asthma symptoms. The drug has shown promise in clinical trials, with results indicating its potential to reduce blood eosinophil counts, a key marker associated with improved lung function. This breakthrough could offer a much-needed accessible treatment option for millions of individuals suffering from this severe form of asthma, allowing them to manage their disease more effectively and improve their quality of life.
Silicon Box
Series B in 2024
Silicon Box is a provider of advanced outsourced semiconductor assembly and testing services, focusing on semiconductor integration. The company offers comprehensive solutions for semiconductor packaging, ranging from initial design to final manufacturing. Its expertise encompasses a variety of applications, including artificial intelligence, high-performance computing, electric vehicles, automotive systems, power management, and mobile chipsets. By specializing in semiconductor design and device integration, Silicon Box aims to streamline the chipset design process, facilitating the development of sophisticated chiplet-based systems while ensuring high-quality semiconductor interconnections. This approach not only reduces design cycles but also lowers costs and power consumption for its customers.
Devoted Health, established in 2017 and headquartered in Newton, Massachusetts, specializes in providing comprehensive healthcare solutions for Medicare beneficiaries in the United States. The company offers Medicare Advantage plans, along with personalized care through dedicated health guides, both in-person and virtually. Devoted Health aims to improve the health and well-being of older Americans by combining access to top local providers, virtual and in-home care through Devoted Medical, and advanced technology to deliver tailored healthcare experiences.
Spear Bio
Seed Round in 2023
Spear Bio is a biotechnology company based in Weston, Massachusetts, founded in 2021. The company specializes in ultrasensitive protein detection technology, which significantly enhances healthcare diagnostics. Its innovative approach enables the quantification of minute protein biomarkers from samples collected at home, facilitating self-testing and telemedicine applications. By allowing clinicians to detect these biomarkers from small sample volumes, Spear Bio's technology integrates seamlessly into existing workflows for sample collection, processing, and detection, thereby improving the overall efficiency of healthcare delivery.
Tenstorrent
Venture Round in 2023
Tenstorrent Inc. is a technology company based in Toronto, Canada, with an additional office in Austin, Texas, founded in 2016. The company specializes in the development and manufacturing of application-specific integrated circuits (ASICs) tailored for machine learning and data processing tasks. Its hardware architecture is designed to support a range of applications, from battery-powered Internet of Things (IoT) devices to large-scale cloud servers, providing scalable solutions for deep learning. Tenstorrent's offerings enable developers and researchers in the artificial intelligence sector to enhance computational performance and adapt algorithms effectively, positioning the company as a key player in advancing AI technology.
Gather Health
Series A in 2023
Gather Health is an international healthcare technology company dedicated to empowering chronic disease patients to enhance their health. The company develops mobile and cloud-based healthcare applications that utilize cutting-edge medical and behavioral research to motivate and educate patients. By connecting physicians, patients, their families, and communities, Gather Health aims to provide continuous and holistic care that leads to improved health outcomes. The rise in chronic diseases such as obesity, diabetes, and hypertension has created a pressing need for effective patient care solutions, especially given the shortage of healthcare providers. Gather Health's flagship product, the Gather Health Diabetes platform, is currently utilized by physicians and patients in various cities across Hong Kong and India, including Mumbai and Bangalore, demonstrating positive health outcomes for users. Headquartered in Hong Kong, with additional offices in Beijing, New York, and India, the company boasts a diverse team of clinicians, health experts, interaction designers, and engineers experienced in the global healthcare landscape.
Zus Health
Series A in 2023
Zus Health is a healthcare technology company founded in 2020 by Jonathan Bush, based in Watertown, Massachusetts. It specializes in developing a healthcare data platform that accelerates the creation of digital health solutions. The platform uniquely integrates health and non-health information, allowing healthcare professionals to gain a comprehensive understanding of patients while sharing clinical and non-clinical data without requiring the same applications. By removing traditional barriers, Zus Health empowers a new generation of healthcare builders to design technologies and services that are more affordable and customizable, aiming to enhance the overall healthcare experience.
Oops is a venture-backed startup founded in 2022 and based in Salt Lake City, Utah. The company provides an online platform that simplifies the process of returning products by offering doorstep services for packing, taping, labeling, and transporting items. By streamlining returns, Oops enables individuals to manage their returns conveniently from home, saving them time, effort, and resources.
Infleqtion
Series B in 2022
Infleqtion, with offices in the United States, United Kingdom, and Australia, specializes in delivering advanced quantum information solutions tailored to meet critical market needs. Building on 17 years of pioneering research from ColdQuanta, the company develops software-configured, quantum-enabled products that enhance precision and processing power for applications in positioning, navigation, timing, global communication security, and efficiency. Infleqtion's technology serves various sectors, including commercial enterprises and governmental organizations, by providing high-value information streams that facilitate innovation in quantum matter. Its offerings encompass hardware products and AI-powered solutions aimed at advancing resilience in energy distribution and accelerating developments in quantum computing.
CareHarmony
Series A in 2022
CareHarmony, LLC is a healthcare company that specializes in whole-person care coordination services, focusing on improving patient experiences and clinical outcomes. Founded in 2015 and based in Brentwood, Tennessee, CareHarmony provides a comprehensive Chronic Care Management solution tailored for physician practices, Accountable Care Organizations, and Independent Practice Associations. The company's platform enhances patient engagement through features such as 24/7 access, mobile app support, personalized care plans, secure file sharing, and streamlined billing assistance. By offering a high-tech, high-touch approach, CareHarmony enables healthcare providers to transition into value-based care with minimal risk, ultimately promoting better health outcomes for patients.
Carta Healthcare
Series B in 2022
Carta Healthcare, Inc. is a technology company that specializes in developing a software-as-a-service platform aimed at improving hospital patient management. Founded in 2016 and headquartered in San Mateo, California, the company leverages data from existing IT systems to map the patient journey through hospitals. Its platform utilizes machine learning to identify similarities between current patients and past patients, allowing healthcare providers to personalize care based on individual needs. Additionally, it predicts potential bottlenecks, such as recovery bed shortages and cancellations, offering alerts that help hospitals optimize their operations. By combining artificial intelligence with human expertise, Carta Healthcare enhances the efficiency and quality of healthcare data management, ultimately aiming to provide a better experience for patients.
Areteia Therapeutics
Series A in 2022
Areteia Therapeutics is a biotechnology company focused on developing innovative treatments for asthma, particularly eosinophilic asthma. Spun out from Knopp in Pennsylvania, the company aims to empower asthma patients by providing them with better control over their condition. Areteia is advancing an oral drug candidate that works by inhibiting the maturation of eosinophils, which are immune cells that can damage the airways and exacerbate asthma symptoms. The drug has shown promise in clinical trials, with results indicating its potential to reduce blood eosinophil counts, a key marker associated with improved lung function. This breakthrough could offer a much-needed accessible treatment option for millions of individuals suffering from this severe form of asthma, allowing them to manage their disease more effectively and improve their quality of life.
Proximie Inc., headquartered in Bedford, Massachusetts, operates a health technology platform that facilitates remote, real-time collaboration among surgeons worldwide. The company's core service enables surgeons to virtually attend operations via augmented reality, artificial intelligence, and machine learning technologies. This allows them to visually guide complex surgeries, demonstrate techniques, and provide expertise remotely, thereby democratizing access to advanced surgical knowledge globally. Founded by Nadine Hachach-Haram in 2016, Proximie aims to enhance surgical outcomes and improve patient care through innovative telehealth solutions.
Coherent is a technology company that specializes in providing software solutions for the insurance industry. Founded in 2018 and headquartered in Causeway Bay, Hong Kong, with additional offices in Shanghai, Singapore, and Manila, Coherent develops applications that enhance product development, sales, and customer engagement for insurance companies. Its flagship offerings include Factory, a tool enabling insurers to digitize backend operations and manage pricing models through Excel; Coherent Connect, a social media marketing campaign manager; Coherent Explainer, which simplifies the quote breakdown process; and Coherent Flow, designed for remote policy sales through features like video chat and electronic signatures. Additionally, the company offers Coherent Spark, a no-code platform that transforms spreadsheet-based business logic into customized APIs, facilitating better integration of software solutions across business operations.
D-ID is a software development company that specializes in face recognition technologies and artificial intelligence solutions for various industries, including Fortune 500 companies. Founded in 2016 and headquartered in Palo Alto, California, with an additional office in Tel Aviv, Israel, D-ID offers a range of products, including de-identification software that enhances identity theft protection and ensures compliance with regulations by removing sensitive biometric data from facial images. The company also provides tools for photo protection, facial blurring, and face authentication. Furthermore, D-ID's technology facilitates the creation of engaging video content through talking avatars, supporting applications in marketing, e-learning, corporate training, and content creation. Their platform is designed to enable natural interactions with technology through AI-generated media, promoting a more personalized user experience.
PrognomIQ
Venture Round in 2022
PrognomiQ is a technology company specializing in transforming the early detection and treatment of complex diseases like cancer. It generates comprehensive proteomic, genomic, and metabolomic data to provide insights into these conditions, aiming to enhance patient outcomes. The company's innovative approach involves developing advanced test products that improve understanding and management of health issues by integrating diverse health data types.
Volta Labs
Series A in 2022
Volta Labs, Inc. is a biotechnology company based in Cambridge, Massachusetts, founded in 2018. The company specializes in engineering and developing innovative tools for biological automation, focusing on scalable automation solutions for genetic engineering. Its platform is designed to revolutionize genomics research by providing affordable genomic sample preparation and automation for complex biological workflows. By integrating expertise from engineering, surface chemistry, and molecular biology, Volta Labs aims to streamline sample processing and enhance the capabilities of biotech organizations in the next generation of genomic automation.
FitOn Inc. is a fitness technology company based in Los Angeles, California, established in 2018. It has developed a fitness application that allows users to participate in live and on-demand workout classes without the need for equipment. The app offers a diverse range of classes, including yoga, Pilates, pre and post-natal workouts, interval training, cardio, dance, and barre, all led by world-class trainers and celebrities. FitOn’s platform has attracted over 12 million members who have collectively logged more than one billion workout minutes. Additionally, the company provides FitOn Health, an enterprise service that partners with over 13,000 employers and major health plans in the United States to offer expert-led programs aimed at individuals managing chronic conditions. The application also features tools for calorie tracking, monitoring heart rates, and sharing progress with friends, enhancing the overall fitness experience.
Lusix
Private Equity Round in 2022
Lusix is a manufacturer of lab-grown diamonds aimed at providing affordable luxury to environmentally and socially conscious consumers. The company utilizes proprietary technology and scientific expertise to cultivate high-yield diamonds that exhibit exceptional quality and color. By focusing on ethical sourcing and environmental sustainability, Lusix caters to the gemstone market and various industrial applications, ensuring that its products meet the growing demand for responsible luxury.
Dewpoint Therapeutics
Series C in 2022
Dewpoint Therapeutics, Inc. is a Boston-based biotech company focused on the research and development of biomolecular condensates, aiming to create innovative treatments for a range of diseases, including cancer, neurodegenerative disorders, immunological conditions, cardiovascular issues, women's health, and viral infections. Founded in 2018, the company utilizes a proprietary platform that combines experimental techniques with machine-learning-based image analysis to visualize and study biomolecular condensates. This technology includes a collection of genetically engineered cell lines designed to track condensates and mitigate harmful protein sequestration. By leveraging its advanced capabilities, Dewpoint Therapeutics seeks to address unmet medical needs and enhance drug discovery across multiple therapeutic areas, collaborating with leading academic and pharmaceutical partners to further its mission.
Clari Inc. is a revenue operations platform based in Sunnyvale, California, founded in 2012. The company utilizes automation and artificial intelligence to consolidate and analyze activity data from various business systems, such as CRM, email, calendar, and marketing automation. This integration provides sales professionals with improved visibility into their deals and relationships, enabling them to close deals more efficiently and reduce manual reporting efforts. Clari's platform offers features like Activity Analytics, which delivers predictive insights and real-time data analysis, allowing sales teams and managers to optimize their strategies, enhance coaching, and effectively allocate resources. By streamlining revenue operations, Clari assists B2B companies, including notable clients like Qualtrics and Adobe, in forecasting business performance, managing pipelines, and minimizing customer churn.
Chapter is a company that specializes in Medicare advisory services aimed at helping seniors navigate their health coverage options. By offering a comprehensive Medicare navigation platform, Chapter assists retirees in making informed decisions regarding their health insurance, ensuring they select coverage that best suits their individual needs while minimizing costs. The platform fosters transparency by aligning the interests of Medicare advisors and consumers, enabling independent recommendations that consider a wide range of options. In addition to health coverage support, Chapter provides retirees with tailored resources such as coupons, tax advice, and technology tips, all designed to enhance their quality of life and security as they age.
Belong Health
Series A in 2021
Belong Health is a health insurance company that focuses on providing Medicare Advantage and special needs plan products. It partners with local health plans to offer regionally informed and humanistic care to a growing community of individuals in need. By developing and enhancing market-leading health plans, Belong Health aims to deliver a straightforward Medicare experience for eligible members, ensuring they have access to quality healthcare through trusted insurance providers. The company's approach emphasizes collaboration with regional partners to address specific healthcare needs and improve the overall member experience.
Heap Inc. is a company that develops an analytics infrastructure designed for online businesses, enabling them to capture and analyze customer interactions across web, mobile, and cloud platforms. Founded in 2012 and headquartered in San Francisco, California, Heap's solution automates the collection and organization of customer behavioral data, such as clicks, transactions, and form submissions, without requiring additional coding. This streamlined approach allows businesses to gain a comprehensive understanding of their users, facilitating informed decision-making and enhancing product development. Heap serves a diverse range of industries, including e-commerce, financial services, and SaaS, with over 6,000 clients that include notable companies across various sectors. The company is committed to empowering organizations to focus on insights and actions that drive business success.
Conveyor
Seed Round in 2021
Conveyor is a leading platform that leverages generative AI to streamline and automate the customer security review process for SaaS companies. By addressing the cumbersome task of managing security questionnaires, Conveyor provides an end-to-end solution that includes a customer-facing trust portal, a GPT-powered tool for generating responses, and a comprehensive questionnaire completion service. This innovative approach significantly reduces the time and effort required by information security teams, enabling them to focus on more critical tasks while building trust with clients. Trusted by top industry players, Conveyor effectively enhances the efficiency of security information sharing and questionnaire management.
FitOn Inc. is a fitness technology company based in Los Angeles, California, established in 2018. It has developed a fitness application that allows users to participate in live and on-demand workout classes without the need for equipment. The app offers a diverse range of classes, including yoga, Pilates, pre and post-natal workouts, interval training, cardio, dance, and barre, all led by world-class trainers and celebrities. FitOn’s platform has attracted over 12 million members who have collectively logged more than one billion workout minutes. Additionally, the company provides FitOn Health, an enterprise service that partners with over 13,000 employers and major health plans in the United States to offer expert-led programs aimed at individuals managing chronic conditions. The application also features tools for calorie tracking, monitoring heart rates, and sharing progress with friends, enhancing the overall fitness experience.
Devoted Health, established in 2017 and headquartered in Newton, Massachusetts, specializes in providing comprehensive healthcare solutions for Medicare beneficiaries in the United States. The company offers Medicare Advantage plans, along with personalized care through dedicated health guides, both in-person and virtually. Devoted Health aims to improve the health and well-being of older Americans by combining access to top local providers, virtual and in-home care through Devoted Medical, and advanced technology to deliver tailored healthcare experiences.
Centivo
Venture Round in 2021
Centivo Corporation is a health insurance provider that specializes in offering innovative health plans for self-funded employers, employees, and clinicians. Established in 2016 and headquartered in Stamford, Connecticut, with additional offices in New York and Buffalo, Centivo serves as an alternative to traditional insurance carriers and third-party administrators. The company integrates technology, network management, claims processing, and customer support to effectively administer health benefits. Centivo emphasizes collaboration between employees and their primary care teams to coordinate healthcare needs, encouraging members to engage in high-value care through personalized matching tools and a user-friendly app. By focusing on controlling costs and improving navigation through the healthcare system, Centivo positions itself as a dedicated partner to employers, ensuring accountability and minimizing waste in healthcare spending.
Chapter is a company that specializes in Medicare advisory services aimed at helping seniors navigate their health coverage options. By offering a comprehensive Medicare navigation platform, Chapter assists retirees in making informed decisions regarding their health insurance, ensuring they select coverage that best suits their individual needs while minimizing costs. The platform fosters transparency by aligning the interests of Medicare advisors and consumers, enabling independent recommendations that consider a wide range of options. In addition to health coverage support, Chapter provides retirees with tailored resources such as coupons, tax advice, and technology tips, all designed to enhance their quality of life and security as they age.
Apna is India's largest professional networking platform, established in 2019 to support the country's emerging workforce by facilitating unique networking and skill development opportunities. The platform serves over 35 million users across 75 cities and has gained the trust of more than 2 million employers. Apna enables users, particularly from the grey and blue-collar sectors, to create comprehensive profiles, connect with potential employers, schedule job interviews, and engage with peers for upskilling. This approach not only helps job seekers find opportunities that align with their skills and aspirations but also allows employers to hire talent more efficiently and cost-effectively. With significant investment backing, Apna is committed to enhancing livelihoods and creating a robust ecosystem for professional growth in India.
House Rx
Seed Round in 2021
House Rx is a health technology platform focused on improving affordability and patient access to specialty medications.
CCC Intelligent Solutions
Post in 2021
CCC Intelligent Solutions is a provider of cloud-based software and technology solutions tailored for the property and casualty insurance sector. Its platform connects over 30,000 businesses, including insurers, repairers, automakers, and part suppliers, by facilitating digital workflows and commerce. CCC specializes in leveraging artificial intelligence, telematics, and hyperscale technologies to enhance customer experiences and streamline operations. The company generates revenue primarily through software subscriptions and professional services and has a significant presence in the United States, with additional operations in China. By delivering innovative solutions, CCC plays a crucial role in digitizing mission-critical processes within the insurance industry.
Zus Health
Series A in 2021
Zus Health is a healthcare technology company founded in 2020 by Jonathan Bush, based in Watertown, Massachusetts. It specializes in developing a healthcare data platform that accelerates the creation of digital health solutions. The platform uniquely integrates health and non-health information, allowing healthcare professionals to gain a comprehensive understanding of patients while sharing clinical and non-clinical data without requiring the same applications. By removing traditional barriers, Zus Health empowers a new generation of healthcare builders to design technologies and services that are more affordable and customizable, aiming to enhance the overall healthcare experience.
Fractyl Health
Series F in 2021
Fractyl Health Inc. is a medical technology company dedicated to developing innovative solutions for the treatment of metabolic diseases, particularly type 2 diabetes and obesity. The company specializes in a minimally invasive procedure known as Revita DMR, or duodenal mucosal resurfacing therapy, which rejuvenates the lining of the duodenum through hydrothermal ablation. This approach aims to remove excessive layers of the duodenal mucosa that accumulate due to unhealthy diets, thereby addressing the root causes of metabolic disorders. Founded in 2010 and based in Lexington, Massachusetts, Fractyl Health seeks to redefine the treatment landscape from chronic management to durable, disease-modifying therapies, ultimately enhancing patient health and reducing the burden on healthcare systems.
Belong Health
Seed Round in 2021
Belong Health is a health insurance company that focuses on providing Medicare Advantage and special needs plan products. It partners with local health plans to offer regionally informed and humanistic care to a growing community of individuals in need. By developing and enhancing market-leading health plans, Belong Health aims to deliver a straightforward Medicare experience for eligible members, ensuring they have access to quality healthcare through trusted insurance providers. The company's approach emphasizes collaboration with regional partners to address specific healthcare needs and improve the overall member experience.
CareMax is a technology-enabled care platform focused on delivering value-based care and chronic disease management for seniors. The company operates a network of medical centers that provide a wide range of healthcare and social services. Additionally, CareMax has developed a proprietary software and services platform that offers data, analytics, and rules-based decision tools to assist physicians in their practice. This integrated approach aims to enhance the quality of care for seniors while managing their healthcare needs effectively across the United States.
Cano Health is a healthcare company focused on providing personalized, value-based primary care services primarily for seniors. Operating across Florida, Texas, Nevada, and Puerto Rico, Cano Health manages primary care centers and supports affiliated medical practices. The company emphasizes high-touch population health management through a comprehensive care coordination strategy that includes wellness activities, pharmacy services, home visits, telehealth, and management of high-risk and complex cases. Serving approximately 310,000 members, Cano Health aims to enhance health outcomes, wellness, and quality of life for its patients and the communities it operates in.
QuintoAndar
Series E in 2021
QuintoAndar is a digital platform that streamlines the rental process for residential real estate in Brazil, catering to both landlords and renters. Founded in February 2013 by Gabriel Braga and Andre Penha, the company is headquartered in São Paulo. QuintoAndar offers a marketplace featuring various rental listings, allowing users to schedule visits and finalize agreements without the burden of paperwork. The platform also provides rental insurance and facilitates recurring payments, eliminating the need for guarantors. By prioritizing transparency and efficiency, QuintoAndar aims to enhance the rental experience for all parties involved.
Mon Ami
Seed Round in 2021
Mon Ami, Inc. is a company based in Palo Alto, California, founded in 2018, that focuses on enhancing connections between college students and seniors. Its application addresses the needs of individuals facing social isolation due to various health conditions, such as dementia, Alzheimer’s, Parkinson’s disease, autism, and cancer, by facilitating meetings between companions and families. Mon Ami also offers a software-as-a-service (SaaS) platform designed to assist state and local aging and disability service providers. This platform is HIPAA compliant and aims to streamline operations, reduce administrative burdens, and enhance the capacity of these providers to deliver essential services to seniors. By partnering with agencies across the country, Mon Ami seeks to improve the well-being of older adults while enabling caregivers to operate more efficiently.
SnapDocs, Inc. is a real estate technology company that specializes in digital mortgage closings. Founded in 2013 and headquartered in San Francisco, California, SnapDocs provides a platform that connects lenders, title companies, notary signing agents, and homebuyers, facilitating a streamlined closing process. The platform automates interactions among these participants, ensuring efficiency, accuracy, and consumer satisfaction. It offers features such as performance metrics for mobile notary signing agents, customizable workflows for lenders and real estate professionals, and early access to closing packages for homebuyers. By leveraging advanced automation and patented technology, SnapDocs enhances the closing experience, enabling clients to save time and reduce costs while maintaining compliance. The company's focus on improving both borrower experience and business outcomes positions it as a leading solution in the mortgage closing industry.
Infleqtion
Convertible Note in 2021
Infleqtion, with offices in the United States, United Kingdom, and Australia, specializes in delivering advanced quantum information solutions tailored to meet critical market needs. Building on 17 years of pioneering research from ColdQuanta, the company develops software-configured, quantum-enabled products that enhance precision and processing power for applications in positioning, navigation, timing, global communication security, and efficiency. Infleqtion's technology serves various sectors, including commercial enterprises and governmental organizations, by providing high-value information streams that facilitate innovation in quantum matter. Its offerings encompass hardware products and AI-powered solutions aimed at advancing resilience in energy distribution and accelerating developments in quantum computing.
Collective Health
Series F in 2021
Collective Health is a health benefits platform that integrates various medical, dental, vision, and pharmacy services into a cohesive solution aimed at simplifying healthcare for employees and their families. The company’s cloud-based platform streamlines the administration of health plans through a single portal, offering clear guidance, live concierge support, and digital tools for managing care. By reducing the administrative burden associated with health benefits, Collective Health enhances the member experience and aids organizations in controlling costs while improving health outcomes. Headquartered in San Francisco, California, the company also has offices in Chicago, Illinois, and Lehi, Utah.
Proximie Inc., headquartered in Bedford, Massachusetts, operates a health technology platform that facilitates remote, real-time collaboration among surgeons worldwide. The company's core service enables surgeons to virtually attend operations via augmented reality, artificial intelligence, and machine learning technologies. This allows them to visually guide complex surgeries, demonstrate techniques, and provide expertise remotely, thereby democratizing access to advanced surgical knowledge globally. Founded by Nadine Hachach-Haram in 2016, Proximie aims to enhance surgical outcomes and improve patient care through innovative telehealth solutions.
Carta Healthcare
Series A in 2021
Carta Healthcare, Inc. is a technology company that specializes in developing a software-as-a-service platform aimed at improving hospital patient management. Founded in 2016 and headquartered in San Mateo, California, the company leverages data from existing IT systems to map the patient journey through hospitals. Its platform utilizes machine learning to identify similarities between current patients and past patients, allowing healthcare providers to personalize care based on individual needs. Additionally, it predicts potential bottlenecks, such as recovery bed shortages and cancellations, offering alerts that help hospitals optimize their operations. By combining artificial intelligence with human expertise, Carta Healthcare enhances the efficiency and quality of healthcare data management, ultimately aiming to provide a better experience for patients.
KUDO, Inc., also known as Kudo Technologies, is a New York-based company that provides a language as a service (LaaS) platform designed for multilingual online meetings. Founded in 2016, KUDO offers a cloud-based software as a service (SaaS) solution that includes video conferencing tools with integrated support for translators and multiple audio streams. The platform facilitates multilingual live events and web conferencing, allowing businesses to communicate effectively with global audiences in their preferred languages. KUDO's innovative approach enables participants and interpreters to connect from anywhere in the world using standard computers or smartphones, making it a cost-effective option for reaching diverse markets.
Cityblock
Series C in 2021
Cityblock Health, Inc., established in 2017 and headquartered in Brooklyn, New York, operates a personalized health system tailored to meet the unmet health and social needs of Medicaid and Medicare populations. The company's online platform offers integrated primary care, behavioral health, and virtual care services, along with a tool called Commons for communication, information sharing, and task management. Cityblock's model focuses on upstream investment in highly personalized, prevention-oriented care, aiming to improve outcomes and reduce costs. It partners with community-based organizations to deliver care, enabling clinicians to provide personalized care for each member. During the COVID-19 pandemic, Cityblock developed a model to help identify high-risk members within organizations.
Cylera, Inc. is a cybersecurity company specializing in protecting healthcare organizations from cyber threats and malware. Founded in 2017 and based in New York, Cylera offers a comprehensive platform that integrates advanced cybersecurity solutions tailored for the Internet of Things (IoT) in healthcare. The company's patented technology enables asset management, risk analysis, and threat detection, providing a centralized approach to cybersecurity. By identifying all connected devices within healthcare environments, Cylera's software analyzes risks and vulnerabilities, allowing organizations to respond to threats in real-time. This holistic, asset-centric platform aids healthcare providers, enterprises, and government agencies in enhancing their cybersecurity posture and ensuring the safety of critical medical devices and data.
Caribou Biosciences
Series C in 2021
Caribou Biosciences, Inc. is a biotechnology company based in Berkeley, California, that specializes in cellular engineering and genome editing solutions using CRISPR technology. Incorporated in 2011, the company has developed a CRISPR-Cas gene editing platform that allows precise modifications to DNA, which is applicable across various fields including human and animal therapeutics, agricultural biotechnology, and industrial biotech. Caribou's innovative approach aims to create transformative therapies, particularly in the development of allogeneic CAR-T and CAR-NK cell therapies, targeting serious diseases. The company focuses on advancing its pipeline of next-generation genome-edited cell therapies while also contributing to basic and applied biological research.
Garner Health
Series A in 2021
Garner Health is a technology company established in 2019 and based in New York, NY, that focuses on enhancing the healthcare experience for employees through employer partnerships. By leveraging a doctor quality analytics platform, Garner Health provides insights into clinical quality and total care costs, helping employers direct their employees to high-quality healthcare providers. The platform also offers an overlay account that covers employee deductibles and coinsurance, allowing employees to reduce out-of-pocket expenses while ensuring employers achieve guaranteed savings. Through this approach, Garner Health aims to improve healthcare quality and affordability for both employees and their employers.
Cityblock
Series C in 2020
Cityblock Health, Inc., established in 2017 and headquartered in Brooklyn, New York, operates a personalized health system tailored to meet the unmet health and social needs of Medicaid and Medicare populations. The company's online platform offers integrated primary care, behavioral health, and virtual care services, along with a tool called Commons for communication, information sharing, and task management. Cityblock's model focuses on upstream investment in highly personalized, prevention-oriented care, aiming to improve outcomes and reduce costs. It partners with community-based organizations to deliver care, enabling clinicians to provide personalized care for each member. During the COVID-19 pandemic, Cityblock developed a model to help identify high-risk members within organizations.
Centivo Corporation is a health insurance provider that specializes in offering innovative health plans for self-funded employers, employees, and clinicians. Established in 2016 and headquartered in Stamford, Connecticut, with additional offices in New York and Buffalo, Centivo serves as an alternative to traditional insurance carriers and third-party administrators. The company integrates technology, network management, claims processing, and customer support to effectively administer health benefits. Centivo emphasizes collaboration between employees and their primary care teams to coordinate healthcare needs, encouraging members to engage in high-value care through personalized matching tools and a user-friendly app. By focusing on controlling costs and improving navigation through the healthcare system, Centivo positions itself as a dedicated partner to employers, ensuring accountability and minimizing waste in healthcare spending.
Infleqtion
Series A in 2020
Infleqtion, with offices in the United States, United Kingdom, and Australia, specializes in delivering advanced quantum information solutions tailored to meet critical market needs. Building on 17 years of pioneering research from ColdQuanta, the company develops software-configured, quantum-enabled products that enhance precision and processing power for applications in positioning, navigation, timing, global communication security, and efficiency. Infleqtion's technology serves various sectors, including commercial enterprises and governmental organizations, by providing high-value information streams that facilitate innovation in quantum matter. Its offerings encompass hardware products and AI-powered solutions aimed at advancing resilience in energy distribution and accelerating developments in quantum computing.
Dewpoint Therapeutics
Series B in 2020
Dewpoint Therapeutics, Inc. is a Boston-based biotech company focused on the research and development of biomolecular condensates, aiming to create innovative treatments for a range of diseases, including cancer, neurodegenerative disorders, immunological conditions, cardiovascular issues, women's health, and viral infections. Founded in 2018, the company utilizes a proprietary platform that combines experimental techniques with machine-learning-based image analysis to visualize and study biomolecular condensates. This technology includes a collection of genetically engineered cell lines designed to track condensates and mitigate harmful protein sequestration. By leveraging its advanced capabilities, Dewpoint Therapeutics seeks to address unmet medical needs and enhance drug discovery across multiple therapeutic areas, collaborating with leading academic and pharmaceutical partners to further its mission.
Galecto is a clinical-stage biotechnology company focused on developing small-molecule therapeutics to address severe diseases, particularly fibrosis and cancer. Established in 2011, Galecto builds on over a decade of research into the roles of galectin-3 and lysyl oxidase-like 2 (LOXL2) in fibrotic diseases. The company's lead product candidate, GB0139, is an inhaled galectin-3 inhibitor specifically designed for treating severe fibrotic lung diseases, such as idiopathic pulmonary fibrosis (IPF), where there is a significant unmet medical need. Additionally, Galecto is advancing GB1211, an oral selective galectin-3 inhibitor aimed at addressing fibrosis related to non-alcoholic steatohepatitis. With a robust patent portfolio, Galecto leverages its unique therapeutic platform to target the underlying biological processes associated with fibrosis and related diseases.
PrognomIQ
Venture Round in 2020
PrognomiQ is a technology company specializing in transforming the early detection and treatment of complex diseases like cancer. It generates comprehensive proteomic, genomic, and metabolomic data to provide insights into these conditions, aiming to enhance patient outcomes. The company's innovative approach involves developing advanced test products that improve understanding and management of health issues by integrating diverse health data types.
Orasis Pharmaceuticals
Series C in 2020
Orasis Pharmaceuticals Ltd is a pharmaceutical company based in Herzliya, Israel, founded in 2015. The company specializes in the development of corrective eye drops aimed at treating presbyopia, a common age-related vision condition. Its primary product, CSF-1, is designed to improve near visual acuity through pupil modulation, thereby alleviating the need for reading glasses. By repurposing existing, well-studied molecules, CSF-1 aims to provide an effective, safe, and easy-to-use solution that enhances the quality of life for individuals affected by presbyopia. This noninvasive treatment option offers patients a practical alternative for managing their near vision difficulties.
Decent Inc. is a health insurance provider based in Mill Valley, California, that focuses on offering affordable medical insurance plans tailored for self-employed professionals. Founded in 2018, the company aims to improve healthcare access by aligning incentives to enhance health outcomes and reduce costs. One of its key offerings is the Trailblazer Plan, a comprehensive health plan designed specifically for freelancers. By prioritizing the needs of its members, Decent seeks to create a more effective and personalized healthcare experience.
Octopai is an automated data intelligence platform that assists data teams in managing complex data environments. It provides multilayered data lineage, data discovery, and a data catalog, allowing organizations to trace their data assets and understand the flow of information within their systems. By offering a cross-platform solution that requires minimal intervention and no coding, Octopai helps businesses streamline their data operations, reduce chaos, and enhance trust in their data resources.
Seer, Inc. is a life sciences company that specializes in nanoparticle technology solutions aimed at advancing proteomics research. The company offers Proteograph, an integrated system that includes consumables, automation instrumentation, and proprietary software for conducting proteomics analysis. Seer's products are designed for research applications, targeting academic institutions, life sciences laboratories, and biopharmaceutical companies for non-diagnostic and non-clinical uses. Additionally, Seer is focused on developing a health data platform that enhances early detection of chronic diseases by capturing and translating molecular insights from the proteome, thereby enabling healthcare professionals to identify conditions such as cancer and neurological disorders more accurately and rapidly. Founded in 2017 and headquartered in Redwood City, California, Seer was previously known as Seer Biosciences, Inc. before rebranding in July 2018.
Cityblock
Series B in 2020
Cityblock Health, Inc., established in 2017 and headquartered in Brooklyn, New York, operates a personalized health system tailored to meet the unmet health and social needs of Medicaid and Medicare populations. The company's online platform offers integrated primary care, behavioral health, and virtual care services, along with a tool called Commons for communication, information sharing, and task management. Cityblock's model focuses on upstream investment in highly personalized, prevention-oriented care, aiming to improve outcomes and reduce costs. It partners with community-based organizations to deliver care, enabling clinicians to provide personalized care for each member. During the COVID-19 pandemic, Cityblock developed a model to help identify high-risk members within organizations.
Behalf, Inc. is a financing provider based in New York, established in 2011, with an additional office in Tel Aviv, Israel. The company specializes in facilitating commerce between business-to-business merchants and their customers by offering automated payment solutions, including instant credit and flexible payment terms at the point of sale. Behalf integrates seamlessly into merchants' sales and invoicing processes or online checkout systems, allowing business customers to access financing regardless of the invoice or transaction size. By paying merchants upfront, Behalf enhances their sales and cash flow, while also enabling small businesses to manage their operational efficiency through short-term financing and flexible repayment options.
D-ID is a software development company that specializes in face recognition technologies and artificial intelligence solutions for various industries, including Fortune 500 companies. Founded in 2016 and headquartered in Palo Alto, California, with an additional office in Tel Aviv, Israel, D-ID offers a range of products, including de-identification software that enhances identity theft protection and ensures compliance with regulations by removing sensitive biometric data from facial images. The company also provides tools for photo protection, facial blurring, and face authentication. Furthermore, D-ID's technology facilitates the creation of engaging video content through talking avatars, supporting applications in marketing, e-learning, corporate training, and content creation. Their platform is designed to enable natural interactions with technology through AI-generated media, promoting a more personalized user experience.
BioCatch is a pioneering company specializing in behavioral biometrics, which focuses on analyzing the digital behavior of online users to enhance fraud detection and prevention. By leveraging advanced cognitive science and machine learning, BioCatch provides insights that help financial institutions identify potential risks associated with user interactions while maintaining privacy. The company's technology is designed to combat increasingly sophisticated fraud tactics, including social engineering scams, and to streamline the digital banking experience from account creation to login and beyond. With over a decade of experience and a robust portfolio of patents, BioCatch is committed to driving innovation in the field of digital security, enabling clients to effectively combat fraud while fostering a trusted online environment.
Revuze is a pioneering company specializing in generative AI analysis for consumer insights derived from online reviews. They leverage large language model training to extract valuable insights from verified buyers across various e-commerce platforms. Revuze's cutting-edge solutions enable businesses to integrate review analytics into their marketing and product strategies, facilitating data-driven decision-making. The company offers real-time analysis with intuitive features, dynamic dashboards, and comprehensive reports, ensuring clients stay informed about their market categories' evolving landscape.
ConcertAI
Series B in 2020
ConcertAI is a Boston-based company established in 2018 that specializes in developing a suite of medical research tools focused on oncology. The company aims to enhance care-based oncology research and data analytics through its integrated real-world data and AI-driven solutions. ConcertAI’s offerings are designed to improve oncology health outcomes and clinical trial efficiency by utilizing custom patient surveys. This enables pharmaceutical companies to assess existing treatments and advance the development of new therapies. By facilitating the generation of real-world evidence and insights, ConcertAI assists project teams, medical experts, and scientists in delivering impactful research and innovations in cancer care.
Bounce (formerly known as Metro Bikes) is a smart mobility solution, with a mission of making daily commute stress-free, time-saving, reliable, and convenient. With a breakthrough technology that lets users access the bike with just an OTP, the Keyless bikes, have not only done away with keys, but the whole process of renting a bike has just become devoid of any physical or human intervention. With Bounce's new One Way Rental service, users can now pick up and drop the bike anywhere they need to and be done with the ride. This is aimed at providing a seamless first mile and last-mile connectivity to metro users. Founded in 2014, Bounce aims at decongesting the roads by encouraging commuters to choose public transport by delivering convenient options to rent bikes and reach their destinations from metro stations. It is based in Bangalore, India.
Seer, Inc. is a life sciences company that specializes in nanoparticle technology solutions aimed at advancing proteomics research. The company offers Proteograph, an integrated system that includes consumables, automation instrumentation, and proprietary software for conducting proteomics analysis. Seer's products are designed for research applications, targeting academic institutions, life sciences laboratories, and biopharmaceutical companies for non-diagnostic and non-clinical uses. Additionally, Seer is focused on developing a health data platform that enhances early detection of chronic diseases by capturing and translating molecular insights from the proteome, thereby enabling healthcare professionals to identify conditions such as cancer and neurological disorders more accurately and rapidly. Founded in 2017 and headquartered in Redwood City, California, Seer was previously known as Seer Biosciences, Inc. before rebranding in July 2018.
Infleqtion
Seed Round in 2019
Infleqtion, with offices in the United States, United Kingdom, and Australia, specializes in delivering advanced quantum information solutions tailored to meet critical market needs. Building on 17 years of pioneering research from ColdQuanta, the company develops software-configured, quantum-enabled products that enhance precision and processing power for applications in positioning, navigation, timing, global communication security, and efficiency. Infleqtion's technology serves various sectors, including commercial enterprises and governmental organizations, by providing high-value information streams that facilitate innovation in quantum matter. Its offerings encompass hardware products and AI-powered solutions aimed at advancing resilience in energy distribution and accelerating developments in quantum computing.
Remrise
Seed Round in 2019
Remrise, Inc. is a health and wellness company founded in 2018 and headquartered in San Francisco, California. The company specializes in personalized sleep aids that utilize drug-free, plant-based ingredients to enhance sleep quality. Customers begin their experience by taking a quiz that helps identify their specific sleep challenges, allowing Remrise to provide tailored sleep formulas. The key ingredients in these formulas include Reishi, Spine Date Seed, and L-Theanine. Additionally, Remrise offers a user-friendly application for tracking sleep patterns, helping individuals monitor their progress over time. The company focuses on integrating both Eastern and Western herbal traditions to support holistic health and improve overall well-being.
Bungalow is a residential real estate platform founded in 2016 by Andrew Collins and Justin McCarty, headquartered in San Francisco, California. The company focuses on providing convenient and flexible living solutions for renters, particularly early career professionals, by offering multi-bedroom homes in desirable neighborhoods across seven major U.S. cities. Bungalow signs long-term leases with homeowners and then furnishes these homes, providing private bedrooms and matching tenants with compatible housemates. Each furnished home includes amenities such as Wi-Fi, utilities, and housekeeping, along with monthly community events to foster social interaction among residents. This approach enables renters to enjoy high-quality living spaces while building a close-knit community.
HumanFirst
Seed Round in 2019
HumanFirst is a company focused on enhancing patient-centered clinical trials through its advanced precision measures platform, which is recognized as the world's largest AI-powered software-as-a-service solution for improving health outcomes. The platform offers insights and validated evidence data to support biopharmaceutical companies in their drug development processes, enabling them to incorporate digital health technologies, digital biomarkers, and electronic clinical outcome assessments. By providing industry educational tools and facilitating collaboration with research partners, HumanFirst helps biopharma organizations increase research efficiency and accelerate the deployment of innovative treatments. The platform has been utilized by a significant majority of the largest pharmaceutical companies globally, underscoring its role in transforming clinical research and driving the evolution of drug development.
Science Exchange
Debt Financing in 2019
Science Exchange, Inc. operates an online marketplace that facilitates collaboration between researchers and scientific service providers, including academic and government laboratories. Founded in 2011 and based in Palo Alto, California, the company enables users to search for, compare, and procure scientific services from U.S. research institutions, streamlining the process of obtaining quotes, managing projects, and processing payments. The platform enhances research and development productivity by automating various collaborative tasks while ensuring data security and regulatory compliance. By matching researchers seeking to outsource experiments with qualified service providers, Science Exchange makes it easier and more affordable for scientific institutions and researchers to access outsourced research and development services, ultimately accelerating the pace of scientific discovery.
Science Exchange
Venture Round in 2019
Science Exchange, Inc. operates an online marketplace that facilitates collaboration between researchers and scientific service providers, including academic and government laboratories. Founded in 2011 and based in Palo Alto, California, the company enables users to search for, compare, and procure scientific services from U.S. research institutions, streamlining the process of obtaining quotes, managing projects, and processing payments. The platform enhances research and development productivity by automating various collaborative tasks while ensuring data security and regulatory compliance. By matching researchers seeking to outsource experiments with qualified service providers, Science Exchange makes it easier and more affordable for scientific institutions and researchers to access outsourced research and development services, ultimately accelerating the pace of scientific discovery.
Mon Ami
Seed Round in 2019
Mon Ami, Inc. is a company based in Palo Alto, California, founded in 2018, that focuses on enhancing connections between college students and seniors. Its application addresses the needs of individuals facing social isolation due to various health conditions, such as dementia, Alzheimer’s, Parkinson’s disease, autism, and cancer, by facilitating meetings between companions and families. Mon Ami also offers a software-as-a-service (SaaS) platform designed to assist state and local aging and disability service providers. This platform is HIPAA compliant and aims to streamline operations, reduce administrative burdens, and enhance the capacity of these providers to deliver essential services to seniors. By partnering with agencies across the country, Mon Ami seeks to improve the well-being of older adults while enabling caregivers to operate more efficiently.
Heap Inc. is a company that develops an analytics infrastructure designed for online businesses, enabling them to capture and analyze customer interactions across web, mobile, and cloud platforms. Founded in 2012 and headquartered in San Francisco, California, Heap's solution automates the collection and organization of customer behavioral data, such as clicks, transactions, and form submissions, without requiring additional coding. This streamlined approach allows businesses to gain a comprehensive understanding of their users, facilitating informed decision-making and enhancing product development. Heap serves a diverse range of industries, including e-commerce, financial services, and SaaS, with over 6,000 clients that include notable companies across various sectors. The company is committed to empowering organizations to focus on insights and actions that drive business success.
Seer, Inc. is a life sciences company that specializes in nanoparticle technology solutions aimed at advancing proteomics research. The company offers Proteograph, an integrated system that includes consumables, automation instrumentation, and proprietary software for conducting proteomics analysis. Seer's products are designed for research applications, targeting academic institutions, life sciences laboratories, and biopharmaceutical companies for non-diagnostic and non-clinical uses. Additionally, Seer is focused on developing a health data platform that enhances early detection of chronic diseases by capturing and translating molecular insights from the proteome, thereby enabling healthcare professionals to identify conditions such as cancer and neurological disorders more accurately and rapidly. Founded in 2017 and headquartered in Redwood City, California, Seer was previously known as Seer Biosciences, Inc. before rebranding in July 2018.
1mg is an Indian digital healthcare platform, launched in 2015, that operates from Gurgaon, Haryana. It aims to make healthcare more accessible, understandable, and affordable. The platform enables users to find detailed information about prescribed medicines, buy them, and search for drugs based on ailments, classes, companies, and brands. Additionally, 1mg offers a doctor platform to help users find suitable healthcare professionals and a diagnostics service for transparent and cost-effective lab tests. The company empowers consumers and caregivers to choose the most appropriate healthcare services at competitive prices.
Aptible Inc. is a technology company that provides a security management platform designed to automate HIPAA compliance for web and mobile developers, primarily serving digital health companies. Founded in 2013 and based in San Francisco, Aptible offers two main products: Aptible Enclave, a Docker-based platform that facilitates secure deployment into private AWS environments, and Aptible Gridiron, which assists cloud-based software engineering teams with security management. The company's platform as a service (PaaS) enables startups and scaling businesses to efficiently provision, manage, and scale their infrastructure, allowing developers to concentrate on product development rather than underlying complexities. Aptible's solutions incorporate essential enterprise requirements such as security, compliance, and reliability from the outset, ensuring that developers can build and grow their applications with ease.
Bounce (formerly known as Metro Bikes) is a smart mobility solution, with a mission of making daily commute stress-free, time-saving, reliable, and convenient. With a breakthrough technology that lets users access the bike with just an OTP, the Keyless bikes, have not only done away with keys, but the whole process of renting a bike has just become devoid of any physical or human intervention. With Bounce's new One Way Rental service, users can now pick up and drop the bike anywhere they need to and be done with the ride. This is aimed at providing a seamless first mile and last-mile connectivity to metro users. Founded in 2014, Bounce aims at decongesting the roads by encouraging commuters to choose public transport by delivering convenient options to rent bikes and reach their destinations from metro stations. It is based in Bangalore, India.
Collective Health
Series E in 2019
Collective Health is a health benefits platform that integrates various medical, dental, vision, and pharmacy services into a cohesive solution aimed at simplifying healthcare for employees and their families. The company’s cloud-based platform streamlines the administration of health plans through a single portal, offering clear guidance, live concierge support, and digital tools for managing care. By reducing the administrative burden associated with health benefits, Collective Health enhances the member experience and aids organizations in controlling costs while improving health outcomes. Headquartered in San Francisco, California, the company also has offices in Chicago, Illinois, and Lehi, Utah.